Rising number of cancer detected patients across the globe is one of the main drivers for the apoptosis market. Research and development efforts by companies as well as universities, sometimes in collaboration, is another factor augmenting the growth of this market. Lack of awareness is one factor that can potentially restrain the growth of this market.
An important section on patent analysis is included in this report that explores some of the most influential patents and potential indications for apoptosis modulation.?Apoptosis Market
The Apoptosis market can be segmented on the basis of mechanism as:
Caspase Activators and Inhibitors
The Apoptosis market has also been segmented on the basis of the class of drugs as:
First generation indirect apoptogens
second generation indirect apoptogens
reagents and kits
One of the main application of apoptosis is for the treatment of cancer.
In terms of type of disease treatment, the Apoptosis market has been segmented across the following diseases:
North America currenlty accounts for the largest share of the global apoptosis market with Europe coming a close second. The market in emerging and developing economies in APAC and South America are expected to grow at higher rates comparatively till the end of the forecast period.
The market has been segmented based on the following geographies:
Following are just a few of the companies that are operating in the Apoptosis market:
Aegera Therapeutics Inc
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Apoptosis - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Apoptosis - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Apoptosis Market
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Apoptosis Market - Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Apoptosis Market - By Mechanism:
6.1. Bcl-2 Modulators
6.2. Caspase Activators and Inhibitors
6.3. p53 Modulators
6.4. Molecular Pathways
6.5. Protease/Proteasome Inhibitors
7. Apoptosis Market - By Drug Class:
7.1. Direct Apoptogens
7.2. First Generation Indirect Apoptogens
7.3. Second Generation Indirect Apoptogens
7.4. Reagents and Kits
8. Apoptosis Market - By Type of Disease Treatment:
8.1. Neurodegenerative Diseases
8.2. Cardiovascular Diseases
9. Apoptosis Market - By Geography:
9.2. Global Study
9.3.1. North America
10. Apoptosis Market - Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, JVs and Partnerships
11. Company Profiles
11.1. Abbott Laboratories Inc.
11.2. Zentaris GmbH
11.4. AbGenomics International Inc.
11.5. Aegera Therapeutics Inc.
11.6. ApopLogic Pharmaceuticals Inc.
11.7. Infinity Pharmaceuticals Inc.
11.8. Genta Inc.
11.9. Anavex Life Sciences Corporation
11.10. Chromo Therapeutics Limited
11.11. Amgen Inc.
11.12. EntreMed Inc.
11.13. Pfizer Inc.
"*Financials would be provided on a best efforts basis for private companies"
12.3. Research Methodology
12.5. Compilation of Expert Insights